# Microvascular dysfunction and aberrant network activity drive reduced brain oxygenation in a mouse tauopathy model

**Authors:** Sung Ji Ahn, Antoine Anfray, Yun Losson, Mirna El Khatib, Liping Qian, Belem Yoval-Sánchez, Gang Wang, Ping Zhou, Alexander Galkin, Laibaik Park, Sergei Vinogradov, Josef Anrather, Costantino Iadecola

PMC · DOI: 10.21203/rs.3.rs-8205391/v1 · 2025-12-22

## TL;DR

This study shows that tau accumulation in mice causes brain oxygen levels to drop due to disrupted blood flow and excessive neural activity.

## Contribution

The study reveals reduced brain oxygenation as an early, previously unrecognized consequence of tau accumulation.

## Key findings

- Tau causes impaired segmental vasodilation and delayed blood-flow increases in mice.
- Neuronal hyperactivity and poor oxygen delivery lead to episodic hypoxia and metabolic issues.
- These findings suggest therapies to restore cerebral oxygenation could be beneficial.

## Abstract

Tauopathies such as Alzheimer’s disease and frontotemporal dementia are leading causes of cognitive impairment, characterized by accumulation of hyperphosphorylated tau, a microtubule-associated protein, in brain. In addition to driving neural network hyperactivity and neuronal damage, tau disrupts neurovascular function, which may further contribute to disease pathogenesis. Using a mouse tauopathy model, we demonstrate that tau causes a profound breakdown of the normally well-coordinated segmental vasodilation induced by neural activity, resulting in dampened and delayed blood-flow increases, heterogeneous capillary perfusion, and frequent capillary stalling. These neurovascular alterations arise in the context of pronounced network hyperactivity and hypersynchrony, which combined with impaired neurovascular coupling, lead to reduced oxygen availability, episodic hypoxia, and disturbed metabolic homeostasis. Collectively, these findings identify reduced brain oxygenation driven by an imbalance between neuronal hyperactivity and diminished oxygen delivery as a previously-unappreciated early pathogenic consequence of tau accumulation and bolster the rationale for therapies to restore cerebral oxygenation.

## Linked entities

- **Proteins:** MAPT (microtubule associated protein tau)
- **Diseases:** Alzheimer’s disease (MONDO:0004975), frontotemporal dementia (MONDO:0010857)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Spag5 (sperm associated antigen 5) [NCBI Gene 54141] {aka D11Bhm180e, Deepest, MAP126, Mastrin, S17}
- **Diseases:** Alzheimer's disease (MESH:D000544), Tauopathies (MESH:D024801), hypoxia (MESH:D000860), neuronal hyperactivity (MESH:D001289), cognitive impairment (MESH:D003072), neuronal damage (MESH:D009410), frontotemporal dementia (MESH:D057180), Microvascular dysfunction (MESH:D017566)
- **Chemicals:** oxygen (MESH:D010100)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12776513/full.md

---
Source: https://tomesphere.com/paper/PMC12776513